Article Text

Download PDFPDF
Anti-TNF and skin inflammation in IBD: a new paradox in gastroenterology?

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors JHN and SD reviewed the literature, wrote and edited the manuscript.

  • Funding JHN is supported by the Deutsche Forschungsgemeinschaft (DFG; grant Ni575/7-1).

  • Competing interests JHN does not have any competing interests. SD has served as a speaker, a consultant and an advisory board member for Schering-Plough, Abbott Laboratories, Merck & Co, UCB Pharma, Ferring, Cellerix, Millenium Takeda, Nycomed, Pharmacosmos, Actelion, Alphawasserman, Genentech, Grunenthal, Pfizer, Astra Zeneca, Novo Nordisk, Cosmo Pharmaceuticals, Vifor, and Johnson and Johnson.

  • Provenance and peer review Commissioned; externally peer reviewed.

Linked Articles